Gather's patient-tracking app builds a database of virtual patients that speeds drug development for hard-to-treat diseases like lupus.
In two weeks, I created their logo and visual identity, codified that work as a design system in Claude, and produced a master investor pitch deck and website.
Two audiences, one brand
I began with research to discover from Gather’s founders what positions them uniquely in this emerging field, and how they hope to launch and grow their business, and extended my findings into aesthetic criteria:
Human warmth
Gather’s consumer population deals with chronic disease; the right tone is warmth, transparency and reassurance. Pharma and investors are less sensitive. So we built a warm patient brand first, then a cooler pharma/investor sub-brand.
Visually "gathered"
Healthcare is scattered across hospitals, patients and pharma that don't talk to each other, and Gather's thesis is uniting them with patients as co-owners of their data.
Fast and rigorous
Calibrated against Unlearn AI (too traditional), Noetik (the target — high-tech but grounded in evidence) and the founder's previous company Valinor (too far toward high-tech), landing at 70/30 scientific to high-tech.
Logo sketching and evolution
Consumer branding
Pharma branding
Much is written about the power of AI in design, and I was eager to explore (see my own analysis here).
How are we making drugs now?
We’re missing a crucial piece: patient data.
Design the molecule
Test the drug in a virtual patient first
Capital raised behind the three leading virtual-patient companies.
Prove it in humans
How are we making drugs now?
We’re missing a crucial piece: patient data.
Investor deck slide animation made with Claude Design (first image); the same slide recut for Demo Day (second)
Branding guidelines PDF outputted from our final Claude design system